NCT02569814.

Methods	Randomised, open‐label, cross‐over assignment trial
Participants	Healthy men, aged 19‐50 years
Interventions	Group1 Fimasartan/amlodipine combination tablet and rosuvastatin individual tablets at 1st day as period I. And then, after wash out for 2 weeks, as period II, Group 1 participants take a fimasartan/amlodipine/rosuvastatin combination tablet at 15th day Group 2 A fimasartan/amlodipine/rosuvastatin combination tablet at 1st day as period I. And then, after wash out for 2 weeks, as period II, Group 2 participants take fimasartan/amlodipine combination tablet and rosuvastatin individual tablets at 15th day
Outcomes	Primary outcome ‐Cmax of fimasartan, amlodipine and rosuvastatin Secondary outcome ‐AUCt (Area Under the Curve) of fimasartan, amlodipine and rosuvastatin
Notes